H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) shares dropped 49.5% on Thursday. The stock traded as low as $2.02 and last traded at $2.02. 400 shares traded hands during mid-day trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Stock Down 49.5%
The business’s 50 day moving average is $2.02 and its two-hundred day moving average is $2.02.
About H-CYTE
H-CYTE, Inc is a medical technology company focused on developing and commercializing noninvasive therapeutic products based on photobiomodulation, a treatment approach that uses specific wavelengths of light to stimulate biological responses in the body.
The company’s principal product is the H-Cyte System, a light-based therapy platform designed for use by healthcare providers. The system has been promoted for applications involving chronic health conditions, including respiratory and pain-related disorders.
See Also
- Five stocks we like better than H-CYTE
- Plexus Is Booming—But Can the Growth Story Last?
- Conagra’s Turnaround Is Starting to Show Up in the Numbers
- MarketBeat Week in Review – 09/28 – 10/02
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
